Skip to main content
Equibles

Rangeley Capital, LLC

Position in BRNS — Barinthus Biotherapeutics plc.

CIK 1517796 NEW CANAAN, CT
Back to BRNS Full portfolio

Position in BRNS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$122,189
+$31,454 QoQ
Shares Held
185,136
+16.1% QoQ
Ownership
0.453%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#5
of 15 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BRNS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rangeley Capital, LLC holds $27,388,910 across 46 Biotechnology names. BRNS ranks #37 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRTA
Prothena Corp Public Ltd Co
 417,270 $4,085,073
2 ABUS
Arbutus Biopharma Corp
 500,000 $2,400,000
3 ABVX
Abivax S.A.
 13,000 $1,732,380
4 TBPH
Theravance Biopharma, Inc.
 99,500 $1,691,500
5 RLYB
Rallybio Corp
 104,850 $1,677,600
6 RVMD
Revolution Medicines, Inc.
 33,700 $1,629,336
7 JANX
Janux Therapeutics, Inc.
 97,978 $1,504,942
8 ARVN
Arvinas, Inc.
 175,590 $1,459,152

All Filings in BRNS

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $122,189 185,136
2026-03-31 $90,735 159,465
2025-12-31 $59,108 84,441